Globetrotting firms: Canada's health biotechnology collaborations with developing countries.
A survey of Canadian biotech firms reveals that their biotech collaborations with developing countries are not only significant but also increasingly reciprocal in terms of the exchange of financial resources and technological know-how.
Ray
Monali
M
McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Daar
Abdallah S
AS
Singer
Peter A
PA
Thorsteinsdóttir
Halla
H
D001709:Biotechnology / Q000458:organization & administration*; D002170:Canada; D002681:China; D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D003906:Developing Countries; D004345:Drug Industry / Q000458:organization & administration; D006801:Humans; D007221:Industry / Q000458:organization & administration*; D007328:Insulin / Q000008:administration & dosage; D007391:International Cooperation; D012106:Research
D007328:Insulin